Switching to nintedanib after discontinuation of pirfenidone due to adverse events in IPF.

References 1 Simonneau G, Gatzoulis MA, Adatia I, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2013; 62: Suppl. 25, D34–D41. 2 von Herbay A, Illes A, Waldherr R, et al. Pulmonary tumor thrombotic microangiopathy with pulmonary hypertension. Cancer 1990; 66: 587–592. 3 Dorfmuller P, Gunther S, Ghigna MR, et al. Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature. Eur Respir J 2014; 44: 1275–1288. 4 Uruga H, Fujii T, Kurosaki A, et al. Pulmonary tumor thrombotic microangiopathy: a clinical analysis of 30 autopsy cases. Intern Med 2013; 52: 1317–1323. 5 Abe H, Hino R, Fukayama M. Platelet-derived growth factor-A and vascular endothelial growth factor-C contribute to the development of pulmonary tumor thrombotic microangiopathy in gastric cancer. Virchows Archiv 2013; 462: 523–531. 6 Montani D, Bergot E, Gunther S, et al. Pulmonary arterial hypertension in patients treated by dasatinib. Circulation 2012; 125: 2128–2137. 7 Ranchoux B, Gunther S, Quarck R, et al. Chemotherapy-induced pulmonary hypertension: role of alkylating agents. Am J Pathol 2015; 185: 356–371. 8 Tashima Y, Abe K, Matsuo Y, et al. Pulmonary tumor thrombotic microangiopathy: FDG-PET/CT findings. Clin Nucl Med 2009; 34: 175–177. 9 Seki Y, Gotou M, Yasuda A, et al. [Secondary pulmonary hypertension due to pulmonary tumor thrombotic microangiopathy diagnosed by open lung biopsy.] Kyobu Geka 2011; 64: 916–919. 10 Uruga H, Morokawa N, Enomoto T, et al. [A case of pulmonary tumor thrombotic microangiopathy associated with lung adenocarcinoma diagnosed by CT-guided lung biopsy.] Nihon Kokyuki Gakkai Zasshi 2008; 46: 928–933. 11 Ota K, Matsuyama M, Kokuho N, et al. [An autopsy case of pulmonary tumor thrombotic microangiopathy complicated with interstitial pneumonia and lipoid pneumonia.] Nihon Kokyuki Gakkai Zasshi 2009; 47: 518–523. 12 Patrignani A, Purcaro A, Calcagnoli F, et al. Pulmonary tumor thrombotic microangiopathy: the challenge of the antemortem diagnosis. J Cardiovasc Med 2014; 15: 828–833. 13 Ogawa A, Yamadori I, Matsubara O, et al. Pulmonary tumor thrombotic microangiopathy with circulatory failure treated with imatinib. Intern Med 2013; 52: 1927–1930.